Novo Nordisk, FDA
Digest more
Novo Nordisk surges after U.S. regulators approve the first GLP-1 pill, while shares of rival pharma giant Eli Lilly decline.
The Danish drugmaker will start selling a pill version of its Wegovy weight-loss medicine in January, after [securing ...
Yahoo Finance Executive Editor Brian Sozzi tracks some of Tuesday's trending tickers, including Novo Nordisk (NVO), Eli Lilly ...
24/7 Wall St. on MSN
Novo Nordisk Strikes First With Oral Wegovy — But Can It Outrun Lilly’s Looming Pill?
Yesterday, the Food and Drug Administration (FDA) approved Novo Nordisk‘s (NYSE:NVO) Wegovy weight-loss pill, the first of its kind. This once-daily tablet uses the same active ingredient — ...
Novo Nordisk A/S (NYSE: NVO) is making headlines as a leading player in the weight-loss drug market, primarily due to its blockbuster medications, Ozempic and Wegovy. With projected sales reaching $17 ...
Tesla’s sales across the European Union, the Euro Free Trade Association and the UK dropped 11.8% year-on-year to 22,801 units in November, according to data released Tuesday by the European ...
Dec 23 (Reuters) - European shares were muted on Tuesday as healthcare sector gains powered by heavyweight Novo Nordisk clinching U.S. approval of its weight loss pill were offset by losses in ...
Novo Nordisk A/S (NYSE: NVO) is one of the Best Non-US Stocks to Buy According to Hedge Funds. On December 12, Novo Nordisk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback